2190

HKSE:2190

Zylox-Tonbridge Medical Technology Co., Ltd.

Stock

HKD

Last Close

11.14

30/08 08:08

Market Cap

3.51B

Beta: -

Volume Today

584K

Avg: 340.27K

PE Ratio

−24.10

PFCF: −12.34

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-66.65M -	-100.47M 50.75%	-199.69M 98.76%	-113.56M 43.13%	-78.73M 30.66%
depreciation and amortization	9.57M -	9.64M 0.68%	13.38M 38.85%	26.27M 96.29%
deferred income tax	-2.72M -	-691K 74.62%	3.85M 656.44%
stock based compensation	7.60M -	23.11M 204.05%	76.21M 229.76%	87.68M 15.05%	85.77M 2.18%
change in working capital	-1.84M -	-14.23M 672.53%	2.83M 119.90%	-72.54M 2,661.30%
accounts receivables	-525K -	884K 268.38%	-329K 137.22%	-574K 74.47%
inventory	-2.30M -	-19.04M 726.66%	-28.28M 48.54%	-61.97M 119.14%
accounts payables	525K -	-884K 268.38%	329K 137.22%	574K 74.47%
other working capital	461K -	4.81M 942.95%	31.11M 547.07%	-10.56M 133.96%
other non cash items	946K -	306K 67.65%	-12.79M 4,278.76%	-19.18M 49.98%	-7.03M 63.33%
net cash provided by operating activities	-53.09M -	-82.33M 55.08%	-116.21M 41.14%	-91.32M 21.41%
investments in property plant and equipment	-41.58M -	-45.14M 8.56%	-89.59M 98.48%	-145.28M 62.15%
acquisitions net			11.48M -	-39.69M 445.58%
purchases of investments	-466M -	-489.20M 4.98%	-3.66B 649.08%	-3.14B 14.31%
sales maturities of investments	416.97M -	285.12M 31.62%	2.43B 750.73%	3.19B 31.53%
other investing activites	22K -	41K 86.36%	-11.38M 27,846.34%	39.69M 448.89%
net cash used for investing activites	-90.59M -	-249.18M 175.05%	-1.33B 433.10%	-95.05M 92.84%
debt repayment	-15M -	-23M 53.33%	-35M 52.17%	-4.89M 86.03%
common stock issued		336.38M -	2.97B 782.42%
common stock repurchased			-9.15M -	-24.64M 169.36%
dividends paid
other financing activites	194.44M -	32.16M 83.46%	-114.26M 455.28%	-722K 99.37%
net cash used provided by financing activities	179.44M -	345.54M 92.56%	2.81B 713.18%	-30.26M 101.08%
effect of forex changes on cash	-109K -	-601K 451.38%	-6.46M 975.37%	3.57M 155.21%
net change in cash	35.65M -	13.43M 62.34%	1.36B 10,020.68%	-213.06M 115.68%
cash at beginning of period	10.48M -	46.13M 340.17%	59.56M 29.10%	1.42B 2,281.56%	1.21B 15.02%
cash at end of period	46.13M -	59.56M 29.10%	1.42B 2,281.56%	1.21B 15.02%	1.21B 0%
operating cash flow	-53.09M -	-82.33M 55.08%	-116.21M 41.14%	-91.32M 21.41%
capital expenditure	-41.58M -	-45.14M 8.56%	-89.59M 98.48%	-145.28M 62.15%
free cash flow	-94.67M -	-127.47M 34.65%	-205.80M 61.45%	-236.60M 14.97%

All numbers in HKD (except ratios and percentages)